The future of peptide‐based drugs

DJ Craik, DP Fairlie, S Liras… - Chemical biology & drug …, 2013 - Wiley Online Library
The suite of currently used drugs can be divided into two categories–traditional 'small
molecule'drugs with typical molecular weights of< 500 Da but with oral bioavailability, and …

Cyclotides: from structure to function

SJ De Veer, MW Kan, DJ Craik - Chemical reviews, 2019 - ACS Publications
This Review explores the class of plant-derived macrocyclic peptides called cyclotides. We
include an account of their discovery, characterization, and distribution in the plant kingdom …

Multifaceted roles of disulfide bonds. Peptides as therapeutics

M Gongora-Benitez, J Tulla-Puche… - Chemical Reviews, 2014 - ACS Publications
In the last century, small-molecule natural products were the main inspiration for most drug
discovery programs based either on high-throughput screening (HTS) or rational design …

On the utility of chemical strategies to improve peptide gut stability

T Kremsmayr, A Aljnabi… - Journal of medicinal …, 2022 - ACS Publications
Inherent susceptibility of peptides to enzymatic degradation in the gastrointestinal tract is a
key bottleneck in oral peptide drug development. Here, we present a systematic analysis of …

Designing macrocyclic disulfide-rich peptides for biotechnological applications

CK Wang, DJ Craik - Nature chemical biology, 2018 - nature.com
Bioactive peptides have potential as drug leads, but turning them into drugs is a challenge
because of their typically poor metabolic stability. Molecular grafting is one approach to …

Antimicrobial peptides in 2014

G Wang, B Mishra, K Lau, T Lushnikova, R Golla… - Pharmaceuticals, 2015 - mdpi.com
This article highlights new members, novel mechanisms of action, new functions, and
interesting applications of antimicrobial peptides reported in 2014. As of December 2014 …

In vivo activation of the p53 tumor suppressor pathway by an engineered cyclotide

Y Ji, S Majumder, M Millard, R Borra, T Bi… - Journal of the …, 2013 - ACS Publications
The overexpression of Hdm2 and HdmX is a common mechanism used by many tumor cells
to inactive the p53 tumor suppressor pathway promoting cell survival. Targeting Hdm2 and …

[PDF][PDF] Orally active peptidic bradykinin B1 receptor antagonists engineered from a cyclotide scaffold for inflammatory pain treatment

CTT Wong, DK Rowlands, CH Wong… - Angewandte Chemie …, 2012 - academia.edu
Chronic pain is a universal health issue associated with numerous medical conditions, for
example after severe burns or following major surgery.[1] Compelling evidence suggests …

Form and function in cyclic peptide natural products: a pharmacokinetic perspective

AT Bockus, CM McEwen… - Current topics in medicinal …, 2013 - ingentaconnect.com
The structural complexity of many natural products sets them apart from common synthetic
drugs, allowing them to access a biological target space that lies beyond the enzyme active …

The cyclotide cycloviolacin O2 from Viola odorata has potent bactericidal activity against Gram-negative bacteria

M Pränting, C Lööv, R Burman… - Journal of …, 2010 - academic.oup.com
Objectives To determine the antibacterial activity of small cyclic plant proteins, ie cyclotides,
and the importance of the surface exposed charged residues for activity. Methods Prototypic …